MoneyWorks4Me

Syncom Formulations (India) informs about revised audited financial results

26 Jun 2018 Evaluate

Syncom Formulations (India) has informed about submission of the Revised Audited Financial Results along with the Auditors Report and Reconciliation Statement of Equity for the Quarter/Year ended 31st March, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..